These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2334630)

  • 1. Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.
    Wierda JM; de Wit AP; Kuizenga K; Agoston S
    Br J Anaesth; 1990 Apr; 64(4):521-3. PubMed ID: 2334630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.
    Muir AW; Houston J; Green KL; Marshall RJ; Bowman WC; Marshall IG
    Br J Anaesth; 1989 Oct; 63(4):400-10. PubMed ID: 2573387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium.
    Cooper R; Mirakhur RK; Clarke RS; Boules Z
    Br J Anaesth; 1992 Sep; 69(3):269-73. PubMed ID: 1389845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
    van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
    Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man.
    Booij LH; Knape HT
    Anaesthesia; 1991 May; 46(5):341-3. PubMed ID: 2035776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intubating conditions and onset of neuromuscular block of rocuronium (Org 9426); a comparison with suxamethonium.
    Huizinga AC; Vandenbrom RH; Wierda JM; Hommes FD; Hennis PJ
    Acta Anaesthesiol Scand; 1992 Jul; 36(5):463-8. PubMed ID: 1321542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium.
    van den Broek L; Hommes FD; Nap HJ; Wierda JM
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():27-30. PubMed ID: 8557002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991).
    Cason B; Baker DG; Hickey RF; Miller RD; Agoston S
    Anesth Analg; 1990 Apr; 70(4):382-8. PubMed ID: 1969251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
    Mayer M; Doenicke A; Hofmann A; Peter K
    Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical comparison of atracurium and vecuronium (Org NC 45).
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Br J Anaesth; 1983 Feb; 55(2):125-9. PubMed ID: 6131682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical observations on Org 9426.
    Scott RP
    Br J Anaesth; 1990 Dec; 65(6):839. PubMed ID: 2265057
    [No Abstract]   [Full Text] [Related]  

  • 13. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a 16-N-homopiperidino analogue of vecuronium on neuromuscular transmission in anaesthetized cats, pigs, dogs and monkeys, and in isolated preparations.
    Muir AW; Anderson K; Marshall RJ; Booij LH; Crul JF; Prior C; Bowman WC; Marshall IG
    Acta Anaesthesiol Scand; 1991 Jan; 35(1):85-90. PubMed ID: 1848738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of rocuronium bromide (ORG 9426).
    Wicks TC
    AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the intubating conditions and maintenance doses of rocuronium].
    Zhang X; Hong X; Guo X
    Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):520-2. PubMed ID: 10923463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium.
    Chetty MS; Pollard BL; Wilson A; Healy TE
    Anaesth Intensive Care; 1996 Feb; 24(1):37-41. PubMed ID: 8669652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of onset of good intubating conditions, respiratory depression and hand muscle paralysis after vecuronium.
    Bencini A; Newton DE
    Br J Anaesth; 1984 Sep; 56(9):959-65. PubMed ID: 6147155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction.
    Tian L; Mehta MP; Prior C; Marshall IG
    Br J Anaesth; 1992 Sep; 69(3):284-7. PubMed ID: 1356399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical responses to ORG 9426 during isoflurane anesthesia.
    Quill TJ; Begin M; Glass PS; Ginsberg B; Gorback MS
    Anesth Analg; 1991 Feb; 72(2):203-6. PubMed ID: 1985504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.